XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -2.48%58.57M | -12.18%36.98M | 135.92%21.21M | 106.02%16.35M | -1,655.01%-15.97M | -25.62%60.06M | 143.77%42.11M | -81.78%8.99M | 121.45%7.94M | -97.99%1.03M |
Net income from continuing operations | -60.83%16.09M | -60.13%3.84M | -58.21%5.35M | -64.09%2.75M | -62.23%4.16M | -59.85%41.08M | -45.18%9.63M | -21.17%12.79M | -82.69%7.65M | -54.75%11.01M |
Operating gains losses | -182.47%-367K | 178.02%253K | -158.93%-221K | -4,153.33%-638K | 4,083.33%239K | 101.47%445K | -46.78%91K | 138.54%375K | 99.95%-15K | -101.24%-6K |
Depreciation and amortization | 12.25%33.35M | 11.02%8.6M | 20.05%9.03M | 9.18%8.22M | 8.51%7.51M | 1.44%29.71M | -24.27%7.74M | 9.78%7.52M | 22.23%7.53M | 14.25%6.92M |
Deferred tax | -173.16%-4.78M | -1,208.41%-2.51M | -87.32%-4.52M | -66.90%1.39M | -81.12%857K | 467.57%6.54M | 109.81%226K | -476.13%-2.41M | 291.31%4.19M | 3,674.80%4.54M |
Other non cashItems | 30.84%420K | 123.46%145K | 526.46%1.82M | -732.62%-1.78M | -35.52%236K | -83.81%321K | -237.95%-618K | -20.92%291K | -74.69%282K | 590.57%366K |
Change in working capital | 57.43%-15.59M | 12.51%19.25M | 121.89%2.63M | 101.23%202K | -49.01%-37.68M | 6.16%-36.63M | 254.10%17.11M | -154.36%-12.02M | 75.35%-16.44M | -251.85%-25.29M |
-Change in other current assets | 63.49%-12.58M | 32.90%11.19M | -684.71%-994K | 55.57%-14.51M | 20.45%-8.27M | -4.29%-34.45M | 96.96%8.42M | -85.38%170K | 31.41%-32.65M | -213.97%-10.4M |
-Change in other current liabilities | 50.15%-1.82M | 34.79%9.47M | 130.68%3.73M | -15.31%13.86M | -93.92%-28.87M | 41.70%-3.65M | 145.75%7.03M | -157.20%-12.14M | 183.16%16.36M | -297.19%-14.89M |
-Change in other working capital | -181.84%-1.2M | -184.74%-1.41M | -124.44%-101K | 663.58%851K | -17,866.67%-539K | 481.35%1.47M | 8,420.00%1.66M | 84.10%-45K | -126.31%-151K | 84.21%-3K |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | -2.48%58.57M | -12.18%36.98M | 135.92%21.21M | 106.02%16.35M | -1,655.01%-15.97M | -25.62%60.06M | 143.77%42.11M | -81.78%8.99M | 121.45%7.94M | -97.99%1.03M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -355.42%-590.03M | -240.51%-269.96M | -201.95%-97.84M | -2,698.11%-119.76M | 64.04%-102.48M | -119.45%-129.56M | -30.86%192.12M | -134.90%-32.4M | -100.84%-4.28M | -170.08%-285M |
Net investment purchase and sale | -207.64%-79.84M | 119.05%15.85M | -556.69%-55.94M | -235.56%-19.46M | 66.05%-20.3M | 64.73%-25.95M | 135.38%7.24M | 134.60%12.25M | 330.36%14.35M | -419.79%-59.79M |
Net proceeds payment for loan | -660.97%-393.84M | -204.67%-219.7M | 8.74%-48.02M | -338.77%-90.05M | 80.87%-36.07M | -107.76%-51.76M | -31.64%209.91M | -1,071.99%-52.61M | -104.63%-20.52M | -110.88%-188.53M |
Capital expenditure | -27.21%-21.45M | ---- | ---- | ---- | ---- | -169.03%-16.86M | ---- | ---- | ---- | ---- |
Net PPE purchase and sale | -162.51%-62.79M | -106.83%-8.24M | 59.93%-815K | 58.84%-1.04M | -242.56%-52.7M | -119.20%-23.92M | -66.69%-3.98M | 30.20%-2.03M | 16.90%-2.52M | -496.51%-15.38M |
Net intangibles purchase and sale | 4.01%-2.92M | --0 | --0 | --0 | 4.01%-2.92M | ---3.04M | --0 | --0 | --0 | ---3.04M |
Net business purchase and sale | ---10M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net other investing changes | -139.02%-19.18M | -532.37%-26.41M | -30.71%6.93M | -309.03%-9.21M | 152.12%9.51M | -285.27%-8.03M | -10,610.26%-4.18M | 9,421.90%10M | -30.13%4.41M | -794.37%-18.25M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -355.42%-590.03M | -240.51%-269.96M | -201.95%-97.84M | -2,698.11%-119.76M | 64.04%-102.48M | -119.45%-129.56M | -30.86%192.12M | -134.90%-32.4M | -100.84%-4.28M | -170.08%-285M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 1,204.55%574.94M | 125.88%73.81M | 215.71%65.24M | 4,781.88%187.04M | -15.22%248.85M | 92.79%-52.05M | 7.62%-285.18M | 83.32%-56.38M | 97.50%-4M | 245.61%293.5M |
Change in federal funds and securities sold for repurchase | --0 | --0 | --0 | --0 | --0 | 80.71%-340K | --0 | --0 | -136.13%-3.21M | 274.90%2.87M |
Increase decrease in deposit | 535.03%843.34M | 122.40%114.13M | 62.55%314.68M | -123.16%-58.95M | 457.77%473.49M | 58.27%-193.86M | -88.72%-509.57M | 156.97%193.59M | 208.33%254.47M | -310.72%-132.34M |
Net issuance payments of debt | -217.56%-264.5M | -117.56%-39.5M | 0.00%-250M | 200.00%250M | -145.00%-225M | 227.02%225M | --225M | ---250M | -25.00%-250M | 2,087.61%500M |
Net commonstock issuance | 95.97%-3.29M | --1K | --0 | 27.63%-3.21M | 99.90%-81K | -6.40%-81.62M | --0 | --0 | 91.23%-4.44M | -5,765.12%-77.19M |
Cash dividends paid | 0.00%-3.21M | 0.00%-802K | 0.00%-801K | 0.00%-802K | 0.00%-801K | 0.00%-3.21M | 0.00%-802K | 0.00%-801K | 0.00%-802K | 0.00%-801K |
Proceeds from stock option exercised by employees | 31.49%2.6M | -106.12%-12K | 63.79%1.37M | --0 | 28.94%1.24M | 33.99%1.98M | --196K | -3.02%834K | ---19K | 57.00%964K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 1,204.55%574.94M | 125.88%73.81M | 215.71%65.24M | 4,781.88%187.04M | -15.22%248.85M | 92.79%-52.05M | 7.62%-285.18M | 83.32%-56.38M | 97.50%-4M | 245.61%293.5M |
Net cash flow | ||||||||||
Beginning cash position | -29.78%286.64M | 44.94%489.28M | 19.96%500.66M | -0.16%417.03M | -29.78%286.64M | 6.53%408.18M | -19.95%337.58M | -42.37%417.38M | 0.97%417.72M | 6.53%408.18M |
Current changes in cash | 135.77%43.48M | -212.40%-159.16M | 85.73%-11.38M | 24,697.06%83.63M | 1,267.86%130.4M | -586.11%-121.55M | -276.08%-50.95M | 73.62%-79.79M | -100.11%-340K | -68.77%9.53M |
End cash position | 15.17%330.12M | 15.17%330.12M | 44.94%489.28M | 19.96%500.66M | -0.16%417.03M | -29.78%286.64M | -29.78%286.64M | -19.95%337.58M | -42.37%417.38M | 0.97%417.72M |
Free cash flow | -276.06%-28.59M | -65.73%7.29M | 193.17%20.4M | 182.61%15.31M | -311.45%-71.59M | -74.46%16.24M | 146.77%21.26M | -85.02%6.96M | 113.54%5.42M | -135.84%-17.4M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |